GIUDICE, VALENTINA
 Distribuzione geografica
Continente #
AS - Asia 11.288
EU - Europa 7.461
NA - Nord America 6.997
SA - Sud America 772
AF - Africa 164
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 10
Totale 26.709
Nazione #
HK - Hong Kong 7.405
US - Stati Uniti d'America 6.822
FI - Finlandia 3.922
SG - Singapore 1.872
IT - Italia 1.437
CN - Cina 708
BR - Brasile 577
DE - Germania 565
VN - Vietnam 534
RU - Federazione Russa 448
ES - Italia 198
IN - India 169
FR - Francia 166
GB - Regno Unito 144
IE - Irlanda 128
UA - Ucraina 128
KR - Corea 111
CA - Canada 99
TR - Turchia 94
AR - Argentina 87
BD - Bangladesh 87
SE - Svezia 68
AT - Austria 55
JP - Giappone 54
NL - Olanda 49
ZA - Sudafrica 45
MX - Messico 41
PL - Polonia 41
CZ - Repubblica Ceca 40
ID - Indonesia 37
IQ - Iraq 37
EC - Ecuador 30
PK - Pakistan 25
ET - Etiopia 24
CO - Colombia 22
UZ - Uzbekistan 21
EG - Egitto 20
MA - Marocco 19
MY - Malesia 17
VE - Venezuela 17
SA - Arabia Saudita 16
CL - Cile 14
PY - Paraguay 13
TN - Tunisia 13
AU - Australia 12
KE - Kenya 12
NP - Nepal 12
PH - Filippine 12
AE - Emirati Arabi Uniti 11
JO - Giordania 10
BE - Belgio 8
EU - Europa 8
HN - Honduras 8
LT - Lituania 8
AL - Albania 7
DZ - Algeria 7
KZ - Kazakistan 7
TH - Thailandia 7
PE - Perù 6
PT - Portogallo 6
JM - Giamaica 5
KG - Kirghizistan 5
MD - Moldavia 5
AO - Angola 4
AZ - Azerbaigian 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
GR - Grecia 4
HR - Croazia 4
IL - Israele 4
LY - Libia 4
MK - Macedonia 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
BJ - Benin 3
CR - Costa Rica 3
GE - Georgia 3
IR - Iran 3
LB - Libano 3
LU - Lussemburgo 3
NO - Norvegia 3
OM - Oman 3
SI - Slovenia 3
SN - Senegal 3
SY - Repubblica araba siriana 3
UY - Uruguay 3
BH - Bahrain 2
BY - Bielorussia 2
CY - Cipro 2
GT - Guatemala 2
HU - Ungheria 2
KH - Cambogia 2
KW - Kuwait 2
LC - Santa Lucia 2
LV - Lettonia 2
RS - Serbia 2
SC - Seychelles 2
SR - Suriname 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
Totale 26.681
Città #
Hong Kong 7.385
Helsinki 3.822
San Jose 965
Singapore 922
Dallas 617
Ashburn 605
Milan 494
Ann Arbor 465
Chandler 453
Munich 390
Woodbridge 326
Princeton 305
Wilmington 190
Council Bluffs 189
Houston 176
Beijing 171
Los Angeles 162
Valencia 157
Jacksonville 150
Rome 143
Naples 142
Ho Chi Minh City 141
Lauterbourg 140
New York 122
The Dalles 116
Dong Ket 112
Dublin 112
Moscow 91
Santa Clara 90
Hanoi 87
Nuremberg 70
Salerno 68
São Paulo 67
Orem 63
Izmir 58
Andover 57
Buffalo 54
Boardman 43
Turku 43
Tokyo 40
Turin 39
Brooklyn 37
Chennai 37
Warsaw 37
Brno 36
Memphis 35
Nanjing 35
Redwood City 35
Washington 35
Frankfurt am Main 32
Montreal 32
Johannesburg 31
Stockholm 31
Amsterdam 30
Atlanta 29
Figino 27
London 27
Manchester 27
Rio de Janeiro 27
Phoenix 26
Seattle 25
Addis Ababa 24
Chicago 24
Fisciano 24
Pune 24
Denver 23
Pellezzano 23
Toronto 23
Vienna 22
Changsha 18
Columbus 18
Düsseldorf 18
Fairfield 18
Haiphong 18
Mumbai 18
Boston 17
Jyväskylä 17
Tashkent 17
Baghdad 16
Belo Horizonte 16
Brasília 16
Poplar 16
Da Nang 15
Hải Dương 15
Seoul 15
Curitiba 14
Norwalk 14
Mexico City 13
Philadelphia 13
Tianjin 13
Ankara 12
Charlotte 12
Dhaka 12
Lahore 12
Lappeenranta 12
Nanchang 12
Quito 12
Cairo 11
Guangzhou 11
San Francisco 11
Totale 21.112
Nome #
3D Biomimetic Scaffold for Growth Factor Controlled Delivery: An in-vitro study of Tenogenic events on Wharton’s Jelly Mesenchymal stem cells 2.033
3D in-vitro cultures of human bone marrow and Wharton’s jelly derived mesenchymal stromal cells show high chondrogenic potential 1.988
Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study 893
Mucosal-Associated Invariant T Cells in T-Cell Non-Hodgkin Lymphomas: A Case Series 713
Low-Density Granulocytes Are Decreased in Acute Myeloid Leukemia and in Myelodysplastic Syndromes with Negative Prognostic Factors 669
Chondrogenic Commitment of human Bone Marrow Mesenchymal Stem Cells in a perfused, hTGF-β1-releasing PLGA microcarrier seeded, collagen hydrogel 577
Hemopoiesis and Immune Cell Perturbations during Venetoclax Plus Azacytidine Treatment in Acute Myeloid Leukemia 498
DECREASED LOW-DENSITY GRANULOCYTES AS POSSIBLE DIAGNOSTIC MARKERS OF MYELODYSPLASTIC SYNDROMES WITH EXCESS OF BLASTS 494
Suitability of Different Cytological Preparations for Molecular Analysis of Advanced Non-Small Cell Lung Cancers 490
Aplastic anemia: Pathophysiology 486
Hodgkin Lymphoma and Hairy Cell Leukemia Arising from Chronic Lymphocytic Leukemia: Case Reports and Literature Review 419
Post-therapy B regulatory cells might early predict relapse in Hodgkin lymphoma 365
Immature forms of low density granulocytes are increased in acute myeloid leukemia and myelodysplastic syndromes 343
WT1 Expression Levels Combined with Flow Cytometry Blast Counts for Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes 337
Cell-free regenerative medicine: identifying the best source of mesenchymal stem cells for skin therapy in Systemic Sclerosis 334
A Rare Immune-Related Mesenteric and retroperitoneal serositis in a Multi-Refractory Hodgkin Lymphoma Patient Successfully Treated with Chylolymphostatic Surgery 325
Involvement of soluble forms of receptor of the urokinase-type plasminogen activator (UPAR) in hematopoietic stem cell homing 318
High-Risk Genetic Multiple Myeloma: From Molecular Classification to Innovative Treatment with Monoclonal Antibodies and T-Cell Redirecting Therapies 316
All Roads Lead to Interferon-γ: From Known to Untraveled Pathways in Acquired Aplastic Anemia 297
Effects of selected preanalytical variables on Dried Blood Spot (DBS) and Volumetric Adsorptive Microsampling (VAMS) based bioanalytical methods for the determination of four β-lactam antibiotics 254
Clinical efficacy of azacytidine and venetoclax and prognostic impact of Tim-3 and galectin-9 in acute myeloid leukemia and high-risk myelodysplastic syndromes: A single-center real-life experience 249
Contribution of peripheral blood mononuclear cells isolated by advanced filtration system to myogenesis of human bone marrow mesenchymal stem cells co-cultured with myoblasts 232
Gender Differences in the Impact of COVID-19 Pandemic on Mental Health of Italian Academic Workers 231
Aptamer-based proteomics of serum and plasma in acquired aplastic anemia 227
Giant plasma cells with multiple immature nuclei in a young woman with newly diagnosed multiple myeloma 218
Cytomegalovirus reactivation is frequent in multiple myeloma patients treated with daratumumab-based regimens 198
Bone marrow mesenchymal stem cells as a possible ruxolitinib reservoir in the bone marrow niche 197
Autologous And Allogeneic Stem Cell Transplantation Is Associated With Long-Lasting Endocrine Disorders 195
Accelerated and persistent bone loss after autologous and allogeneic stem cell transplantation 194
Eltrombopag Improves Hematopoiesis in Patients with Low to Intermediate-2 Risk Myelodysplastic Syndrome (MDS). 193
Continuous maintenance therapy with alternate-day low dose lenalidomide in multiple myeloma patients after autologous stem cell transplantation 181
Anaplastic CD30+ alk- (micro) lymphoma arising out of mediastinal Plasma Cell Castleman’s disease in immunocompetent patient treated by rituximab- dexametasone and continuous lenalidomide 181
High incidence of cytomegalovirus reactivation in patients with lymphoma treated with bendamustine 181
Prolonged azacitidine treatment in the management of elderly patients with high risk myelodysplastic syndromes, chronic myelomonocytic leukemia and acute myeloid leukemia not eligible for standard intensive therapy 178
Circulating T Regulatory Cells Are Persistently Reduced in Non-Severe Acquired Aplastic Anemia 170
Lenalidomide-Mediated NK Cells Expansion In Elderly Multiple Myeloma Patients 170
The Role of B Regulatory Cells in the Immunological Escape of Tumor Cells in Hodgkin Lymphoma 169
Prolonged low-dose lenalidomide treatment increases the number of circulating natural killer cells in multiple mieloma patients 168
67 KDA laminin receptor (67LR) in normal and neoplastic hematopoietic cells: is its targeting a feasible approach? 163
Continuous maintenance therapy with alternate-day low dose lenalidomide in multiple myeloma patients after autologous stem cell transplantation increases the number of circulating natural killer cells 156
Prophylactic therapy with oral low-dose valgancyclovir in cytomegalovirus-positive allogeneic stem cell transplant recipients 154
Induction therapy with continuous alternate-day low dose lenalidomide combined with low-dose prednisone in octogenarian Multiple Myeloma patients 152
Sirt-1 as a novel therapeutic target for improving nitric oxide release in heterozygous and homozygous patients for mthfr mutations 147
Efficacy and safety of splenectomy in adult autoimmune hemolytic anemia. 145
Prolonged complete hematologic response in relapsed/refractory T-large granular lymphocyte leukemia after bendamustine treatment. 143
Cytomegalovirus reactivation prophylaxis with low dose valgancyclovir after hematopoietic stem cell transplantation 142
Electrophysiological Studies in Combination With Interim-Positron Emission Tomography Scan for Prevention of Severe Brentuximab-Vedotin-Induced Neurotoxicity 140
Pre- and Post-COVID-19 Antibiotic Consumption and Stewardship Program in a Southern Italian Hospital 140
Daily low-dose valgancyclovir is safe and effective CMV-reactivation prophylaxis in HLA-identical sibling hematopoietic stem cell transplantation. Bone Marrow Transplantation 140
A simple flow cytometric score based on CD49d and homing marker expression in chronic lymphocytic leukemia (CLL). 138
In vitro apoptotic effects of farnesyltransferase blockade in acute myeloid leukemia cells. 136
Safety of Adjuvanted Recombinant Herpes Zoster Virus Vaccination in Fragile Populations: An Observational Real-Life Study 133
Aptamers and Antisense Oligonucleotides for Diagnosis and Treatment of Hematological Diseases 133
Role of Laparoscopic Splenectomy in Elderly Immune Thrombocytopenia. 133
Urokinase type plasminogen activator receptor (UPAR) as a new therapeutic target in cancer. 132
BRAF V600E mutation associated with papillary high-grade serous ovarian cystadenocarcinoma in a 22q11.2DS patient 130
Reproductive issues in patients undergoing Hematopoietic Stem Cell Transplantation: an update 130
Real-world evidence of cytomegalovirus reactivation in non-Hodgkin lymphomas treated with bendamustine-containing regimens 130
SIRT1 pharmacological activation rescues vascular dysfunction and prevents thrombosis in MTHFR deficiency 125
Combined liposomal amphotericin b and surgery as successful management for pulmunary mucormycosis in a patient with acute myeloid leukemia 125
Flow Cytometric Detection Of B-cell Membrane Markers CD5, CD11c, CD20, CD38 And CD49d May Predict Outcome In Chronic Lymphocytic Leukemia And Non-Hodgkin Lymphoma 124
Therapeutic drug monitoring might identify poor responders to ruxolitinib treatment in myeloproliferative neoplasms 120
BONE MARROW MESENCHYMAL STEM CELLS AS FACILITATOR OF RUXOLITINIB-MEDIATED INHIBITION OF JAK2 MUTADED CELLS 118
Stem Cells from Healthy and Tendinopathic Human Tendons: Morphology, Collagen and Cytokines Expression and Their Response to T3 Thyroid Hormone 118
Advanced biopolymer filtration system for Peripheral Blood Mononuclear Cells collection: a study on filter composition and in vitro filtrate composition 117
Stem cell and macrophage roles in skeletal muscle regenerative medicine 116
Endocrine disorders after autologous and allogeneic stem cell transplantation 114
Endocrinopathies after allogeneic and autologous transplantation of hematopoietic stem cells. 114
How to Improve the Definition of Chronic Lymphocytic Leukemia Outcome Using a Simple Flow Cytometric Score Based on CD49d and Homing Marker Expression 111
Myogenic commitment of human stem cells by myoblasts Co-culture: a static vs. a dynamic approach 111
Peripheral blood mononuclear cells contribute to myogenesis in a 3D bioengineered system of bone marrow mesenchymal stem cells and myoblasts 110
Bone Marrow Failure Syndromes, Overlapping Diseases with a Common Cytokine Signature 109
Clinical Efficacy of Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients 107
Low-dose valgancyclovir as cytomegalovirus reactivation prophylaxis in allogeneic haematopoietic stem cell transplantation. 107
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 107
Sex, Age, and Previous Herpes Zoster Infection Role on Adverse Events Following Immunization with Adjuvanted Recombinant Vaccine 105
Identification of uPAR Variants Acting as ceRNAs in Leukaemia Cells 105
Pharmacogenetics of Carbamazepine and Valproate: Focus on Polymorphisms of Drug Metabolizing Enzymes and Transporters 104
Low-dose valgancyclovir as cytomegalovirus reactivation prophylaxis in allogeneic hematopoietic stem cell transplantation 103
Prophylactic letermovir decreases cytomegalovirus reactivation after stem cell transplantation: a single-center real-world evidence study 103
c-Kit M541L variant is related to ineffective hemopoiesis predisposing to clonal evolution in 3D in vitro biomimetic co-culture model of bone marrow niche 101
Real-world experience with the Sydney System on 1458 cases of lymph node fine needle aspiration cytology 101
Sicurezza del vaccino ricombinante anti-herpes Zoster virus in popolazioni fragili: uno studio osservzionale 100
OPSI threat in hematological patients 99
Gender Differences in Levodopa Pharmacokinetics in Levodopa-Naïve Patients With Parkinson's Disease 97
Clinical Utility of TRBC1 Addition in Multiparametric Flow Cytometry for T Cell Lymphoma Diagnosis 97
Biomimetic proteolipid vesicles for reverting GPI deficiency in paroxysmal nocturnal hemoglobinuria 93
Axitinib in Ponatinib-Resistant B-Cell Acute Lymphoblastic Leukemia Harboring a T315L Mutation 93
Daily low-dose valgancyclovir is safe and effective CMV-reactivation prophylaxis in HLA-identical sibling hematopoietic stem cell transplantation 92
A case series of blastic plasmacytoid dendritic cell neoplasia 92
Reduced Proliferative Potential with Conserved Stem/Stromal Phenotype of Human Umbilical Cord Mesenchymal Stem Cells in Placental Syndromes: A Prospective Cohort Study 89
CD38 prognostic role in chronic lymphocytic leukemia patients treated with standard chemotherapy or targeted agents: a monocentric real-life experience 89
Limited efficacy of 3 + 7 plus gemtuzumab ozogamycin in newly diagnosed fit intermediate genetic risk acute myeloid leukemia patients 88
COVID-19 vaccine-associated lymphadenopathy: a review 88
Successful management of pulmonary mucormycosis with liposomal amphotericin B and surgery treatment: a case report 88
Immunohistochemical algorithms and gene expression profiling in primary cutaneous B-cell lymphoma 87
Non-invasive prenatal test identifies circulating cell-free DNA chromosomal abnormalities derived from clonal hematopoiesis in aggressive hematological malignancies 86
Lenalidomide-induced psoriasis in a refractory multiple myeloma patient successfully treated with narrowband ultraviolet B 85
SERUM FREE LIGHT CHAIN RATIO AS A BIOMARKER OF MULTIPLE MYELOMA PROGRESSION AND ASSOCIATED RENAL DISEASE 85
Implementation of International Prognostic Index with flow cytometry immunophenotyping for better risk stratification of chronic lymphocytic leukemia 85
Totale 22.806
Categoria #
all - tutte 70.620
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.620


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022569 14 2 14 43 16 15 4 17 72 46 75 251
2022/20231.182 94 108 85 129 111 209 54 122 155 4 58 53
2023/2024921 77 90 73 59 71 162 71 71 17 40 53 137
2024/20252.716 76 36 42 84 173 277 662 249 447 122 253 295
2025/202619.418 1.420 3.933 3.465 739 1.158 474 1.320 277 4.389 920 225 1.098
2026/202793 93 0 0 0 0 0 0 0 0 0 0 0
Totale 27.012